Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology.
about
Antifungal Prophylaxis in Immunocompromised PatientsInvasive aspergillosis in acute myeloid leukemia: Are we making progress in reducing mortality?Pandemic 2009 influenza A(H1N1) virus infection coinciding with invasive pulmonary aspergillosis in neutropenic patients.Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study.Clinical effectiveness of posaconazole versus fluconazole as antifungal prophylaxis in hematology-oncology patients: a retrospective cohort study.Guidelines for the management of bacterial and fungal infections during chemotherapy for pediatric acute leukemia or solid tumors: what is available in 2010?Lethal small bowel necrosis due to aspergillosis during acute promyelocytic leukemia inductionAntifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropeniaAntifungal management and resource use in patients with acute myeloid leukaemia after chemotherapy--retrospective analysis of changes over 3 yr in a German hospital.Posaconazole prophylaxis during front-line chemotherapy of acute myeloid leukemia: a single-center, real-life experience.Mould-active compared with fluconazole prophylaxis to prevent invasive fungal diseases in cancer patients receiving chemotherapy or haematopoietic stem-cell transplantation: a systematic review and meta-analysProphylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin: review of the literature.Prospective phase II single-center study of the safety of a single very high dose of liposomal amphotericin B for antifungal prophylaxis in patients with acute myeloid leukemia.Fusarium infection in lung transplant patients: report of 6 cases and review of the literature.Antifungal prophylaxis of patients undergoing allogenetic hematopoietic stem cell transplantation in China: a multicenter prospective observational study.Invasive fungal infections in patients with cancer in the Intensive Care Unit.Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida species.Clinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida species.Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011Comparison of itraconazole, voriconazole, and posaconazole as oral antifungal prophylaxis in pediatric patients following allogeneic hematopoietic stem cell transplantation.Primary antifungal prophylaxis in acute myeloblastic leukemia and myelodysplastic syndrome--still an open question?Effectiveness of primary anti-Aspergillus prophylaxis during remission induction chemotherapy of acute myeloid leukemiaUpdated guidelines for managing fungal diseases in hematology patients.Antifungal prophylaxis in hematopoietic stem cell transplant recipients: the unfinished tale of imperfect success.Use of posaconazole in the treatment of invasive fungal infections.Empiric antifungal therapy in patients with febrile neutropenia.Antifungal prophylaxis during treatment for haematological malignancies: are we there yet?Antifungal treatment strategies in patients with haematological diseases or cancer: from prophylaxis to empirical, pre-emptive and targeted therapy.Amphotericin B lipid complex in the management of invasive fungal infections in immunocompromised patients.Diagnosis of invasive fungal infections in hematology and oncology--guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO).A practical critique of antifungal treatment guidelines for haemato-oncologists.Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors : guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and OncolSecond- versus first-generation azoles for antifungal prophylaxis in hematology patients: a systematic review and meta-analysis.Guideline for primary antifungal prophylaxis for pediatric patients with cancer or hematopoietic stem cell transplant recipients.Therapy of HIV-associated lymphoma-recommendations of the oncology working group of the German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ), in cooperation with the German AIDS Society (DAIG).Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology.Primary antifungal prophylaxis in adult patients with acute lymphoblastic leukaemia: a multicentre audit.Antifungal prophylaxis in newly diagnosed AML patients-Adherence to guidelines and feasibility in a real life setting.A network meta-analysis of primary prophylaxis for invasive fungal infection in haematological patients.Outcome of empirical or targeted antifungal therapy after antifungal prophylaxis in febrile neutropenia.
P2860
Q28074168-523C5431-F473-45FF-8FD3-64B106D7CEA1Q30240242-92D30C76-7785-4E1D-AB13-304DE95F1C23Q30410436-BEC1A8DE-E1A6-4A36-ADAA-C65CB7762067Q30840066-349CFDF5-8C1B-4F8C-8081-E8283339EF46Q33913605-041CD7C2-4523-4CC2-A05E-CEF1FFA80C93Q35010346-47D0A295-F82D-4CE1-B6E0-F67F897996BAQ35116492-D526CF9A-AB3F-40E2-BD38-554A23C8F086Q35589175-0106EF1C-DE7D-4715-A2BE-AA54D6BDE98BQ35700698-0AF05FFC-5BDB-492A-BA7F-F41B121EE180Q35944724-35688FEB-6186-46D5-A010-5052ED63718DQ35949528-E675E6C7-B0F6-4131-BD9F-AD5498A1A80FQ35959480-753A88A1-7098-4E42-80AB-DB7E270ADFFEQ37026715-96FC1A8C-75CC-40F8-90AE-25AE234D8997Q37114436-73AE7099-74E3-4626-9F91-95BC4BE4117FQ37280740-1FB7D0E1-3014-4198-AB24-8C443E2AA433Q37373771-3BBC3012-D159-4F1D-88A0-0C6370096B67Q37450682-46D1986C-26DC-41CE-84F1-8D586AB4B6FCQ37480190-0862020D-EA6E-4057-910A-631361FBEE58Q37544662-AD2D56D4-2125-47CC-9DBE-94679ACEC194Q37636223-81298732-7459-4842-B1FB-E9AC0496D984Q37657464-DC501373-81D9-4C63-AF16-843A5B5A5651Q37713068-C8EFD8A8-49C6-40C5-81BC-E08FF718167FQ37785548-882C9FD7-0FE7-4077-8206-1C0F69D91EBDQ37806065-F1E03739-3D68-4F9C-A03A-23C14A65FCB7Q37810083-D7C74CF9-353C-4036-B8D5-431A3D78659CQ37859365-12C4ED34-D25D-4450-8B49-648020BB0036Q37866827-8DDAB0F1-26ED-4897-92A0-69561248592BQ37873552-B729006B-44B7-4EF3-8C49-CFD67B6E3287Q37925817-4BDB595D-8725-4B74-AC6A-3EC81A250762Q37939026-DAF25386-8109-4466-86AF-FF14E2F32D62Q37983106-1C2429DB-65C3-4B94-9990-D493604CE16BQ38081793-55D1B09F-658A-4C67-B5ED-C0C0E01DDC05Q38086013-26CA5E07-1AB8-4845-83A4-ADBAFBCD0EE8Q38178526-3034722A-89D9-4943-BA49-7A66FC2E8EBFQ38210131-9290CEA6-410F-4954-96E2-30219C1D7635Q38222029-87526324-69B1-48D9-A2E3-98B9C699E3F9Q38620631-96F4BBD2-9776-4315-AC48-385BDC2683FBQ38786258-49C753A9-AE3C-4E1E-B30F-8058429662ACQ39377722-22D96A76-92B2-4242-A09B-A2B91802EC1AQ39883914-A4C4D8E7-72E7-4F8F-8C98-96836238532E
P2860
Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Primary prophylaxis of invasiv ...... for Haematology and Oncology.
@en
Primary prophylaxis of invasiv ...... for Haematology and Oncology.
@nl
type
label
Primary prophylaxis of invasiv ...... for Haematology and Oncology.
@en
Primary prophylaxis of invasiv ...... for Haematology and Oncology.
@nl
prefLabel
Primary prophylaxis of invasiv ...... for Haematology and Oncology.
@en
Primary prophylaxis of invasiv ...... for Haematology and Oncology.
@nl
P2093
P2860
P50
P356
P1433
P1476
Primary prophylaxis of invasiv ...... y for Haematology and Oncology
@en
P2093
Andrew J Ullmann
Angelika Böhme
Georg Maschmeyer
Hans-Heinrich Wolf
Jörg Ritter
Jörg-Janne Vehreschild
Markus Ruhnke
Meinolf Karthaus
Michael Sandherr
Michal Sieniawski
P2860
P304
P356
10.3324/HAEMATOL.11665
P577
2008-12-09T00:00:00Z